CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- 8-K Event Results of operations
- 4 Open-market sale Managing Dir., Dexcom Ventures sold 250 shares at $439.94 ($109,985)
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale EVP, Global Marketing sold 776 shares at $498.75 ($387,030)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale EVP Global Operations sold 1,106 shares at $500.00 ($553,000)
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market sale Managing Dir., Dexcom Ventures sold 250 shares at $459.98 ($114,995)
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale SVP Corporate Development sold 2,186 shares at an average $424.68 ($928,359)
- 4 Open-market sale Chairman, CEO & President sold 3,000 shares at an average $409.77 ($1,229,295)
- 4 Open-market sale EVP, Global Marketing sold 776 shares at $401.27 ($311,386)
- 4 Open-market sale SVP Chief Information Officer sold 2,366 shares at $401.27 ($949,405)
- 4 Returned to the company EVP, Chief Financial Officer returned 1,951 shares (to the company)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 27 of 133 · 2,656 filings